Vitamin D and Stroke
NCT02916030 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2018-07-13
Summary
Stroke remains one of the most devastating neurological diseases, often causing death, or gross physical impairment. It is the second most common cause of death worldwide and a major cause of acquired disability in adults.Vitamin D deficiency has been reported to contribute to the risk of cardiovascular disease especially stroke.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Vit D
It is to examine the relationship between serum 25 (OH) D levels and Stroke either ischemic or hemorrhagic types
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
sayed abd elshafy, MD · associate professor of anesthesia and critical care
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-09-01
- Primary Completion
- 2017-01-02
- Completion
- 2017-01-03
Countries
- Egypt
Study Locations
More Related Trials
-
Effect of Vitamin D3 on Cardiovascular Risk Factors
NCT01501916 ·Status: COMPLETED ·Phase: NA
-
Vitamin D and Mortality in Heart Failure
NCT01326650 ·Status: COMPLETED ·Phase: PHASE4
-
Vitamin D, Insulin Resistance, and Cardiovascular Disease
NCT00736632 ·Status: COMPLETED ·Phase: NA
-
Clinical Effects of Vitamin D Repletion in Patients With Parkinson's Disease
NCT00571285 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy Study of Vitamin D to Treat Contrast-induced Nephropathy
NCT02489240 ·Status: UNKNOWN ·Phase: NA
-
Vitamin D Supplementation in Chronic Stable Heart Failure
NCT01292720 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Vitamin D3 on Vascular Function
NCT00948298 ·Status: COMPLETED ·Phase: NA
-
Vitamin D Deficiency and Replacement on Pulmonary and Endocrine Function in SCI
NCT02099955 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of VitamIN K2 and D3 supplementaTion on PET/MRI in Carotid Artery Disease
NCT04010578 ·Status: UNKNOWN ·Phase: NA
-
Vitamin D Supplementation on Surrogate Markers of Atherosclerosis
NCT05478291 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Vitamin D Supplementation on Exercise Adaptations in Patients on Statin Therapy
NCT02030041 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Bioefficacy of Vitamin D2 and Vitamin D3
NCT01503216 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of the Effect of Vitamin D Supplementation on the Cognitive Function of Older Subjects With Low Levels of This Vitamin
NCT02381600 ·Status: TERMINATED ·Phase: NA
-
Effects of Enteral Supplement Vitamin D Incritically Ill Patients
NCT04292873 ·Status: COMPLETED ·Phase: NA
-
Vitamin D, Cardiovascular Disease, and African Americans
NCT01655810 ·Status: COMPLETED ·Phase: NA
-
The Effect of Vitamin D Supplementation on COVID-19 Recovery
NCT04883203 ·Status: COMPLETED ·Phase: PHASE3
-
Cholecalciferol Supplementation in Critically Ill Patients With Severe Vitamin D Deficiency.
NCT02868827 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Vitamin D Supplementation in Wheelchair Indoor Athletes
NCT02621320 ·Status: COMPLETED ·Phase: NA
-
Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint
NCT02185222 ·Status: COMPLETED ·Phase: PHASE3
-
Metabolic Syndrome and Insulin Resistance at Allina
NCT01545830 ·Status: COMPLETED ·Phase: PHASE2
-
High-dose Vitamin D Supplements in Older Adults
NCT03613116 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Vitamin D Supplementation in Cirrhotic Patients
NCT02009748 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D
NCT01571063 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Vitamin D and Bone Loss in Parkinson's Disease
NCT00907972 ·Status: COMPLETED ·Phase: PHASE2
-
Vitamin D Improves Depression in Liver Patients
NCT02359266 ·Status: COMPLETED ·Phase: NA